Poland· PL-100410976
Sebidin Intensive
A antiseptics product containing chlorhexidini dihydrochloridum + benzocainum, registered in Poland by Perrigo Poland Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Chlorhexidini dihydrochloridum + benzocainum is registered in 2 of 19 countries.
Countries holding a registration under ATC R02AA (antiseptics), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Chlorhexidini dihydrochloridum + benzocainum · ATC R02AA
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Chlorhexidini dihydrochloridum + Benzocainum
- Manufacturer
- Perrigo Poland Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- R02AA
- ATC class
- Antiseptics
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05907734711729
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhexidini dihydrochloridum + benzocainum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainANESTEFARIN 5 mg/5 mg COMPRIMIDOS PARA CHUPARFarline Comercializadora De Productos Farmaceuticos S.A.
- FinlandLangitolSchering Oy
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Bulgaria · Орофар Мента, Хексоралетен Н
- Spain · Anestefarin, Anginocom
- Lithuania · Hexoraletten N
- Portugal · Chex
- Romania · Hexoraletten N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94d8c8a9-31fa-4a64-95f4-19c8101d1af9 GET /v1/drugs/94d8c8a9-31fa-4a64-95f4-19c8101d1af9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki do ssania",
"source": "urpl",
"strength": "5 mg + 5 mg",
"packaging": "05907734711729 ¦ OTC ¦ 129722\n20 tabl.",
"substance": "Chlorhexidini dihydrochloridum 5 mg + Benzocainum 5 mg",
"common_name": "Chlorhexidini dihydrochloridum + Benzocainum",
"pl_product_id": "100410976",
"pozwolenie_nr": "25235",
"auth_procedure": "NAR",
"authorisation_validity": "2024-04-04"
}See everything about chlorhexidini dihydrochloridum + benzocainum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.